EGF-00543 Yellow
CN1CCN(c2nc(NCCN3CCOCC3)c(Br)c(=N)[nH]2)CC1
0.501
Platform Score
2D Structure
C15H26BrN7O | Exact mass: 399.1382
Key Metrics
N/A
Vina (kcal/mol)
#-
Docking Rank
0
Hinge Binder
84
TPSA
400
MW
3
HBD
0.1
SlogP
Display Controls
EGFR Docking Result
N/A
kcal/mol (molecular docking)
| Docking Rank | #- of 1,249 |
| Consensus Score | - |
| Receptor | EGFR (PDB: 1M17) |
| Selective | No |
Selectivity Profile
ADMET Profile
| BBB (BOILED-Egg) | BBB- (non-penetrant) |
| ADMET Status | Pass (no hard fails) |
CNS Drug-Likeness
Physicochemical Properties
| Molecular Weight | 400.30 Da |
| TPSA | 83.5 A^2 |
| HBD | 3 |
| HBA | 7 |
| SlogP | 0.15 |
| Fsp3 | 0.733 |
| Rotatable Bonds | 5 |
| Rings | 3 (1 aromatic) |
| QED | 0.653 |
| SA Score | 2.94 (1=easy, 10=hard) |
| CNS MPO | - / 4.0 |
| Formula | C15H26BrN7O |
| Exact Mass | 399.1382 |
Classification
| Scaffold (Murcko) | - |
| Source Versions | - |
| Best Source Score | - |
| Best Source Rank | #- |
| Hinge Binder | Not present |
| InChIKey | - |
| Filter Pass | Yes |
Retrosynthetic Analysis
Retrosynthetic analysis not yet run for this compound.
About
Retrosynthetic analysis decomposes the target molecule into purchasable building blocks using learned reaction templates.
A feasible route means the molecule can theoretically be synthesized from commercially available starting materials.
Min steps indicates the shortest synthesis route found.